C. Wersinger

发表

Partial regulation of serotonin transporter function by γ-synuclein

A. Sidhu, C. Wersinger, 2009, Neuroscience Letters.

Effect of Taurine and Other Antioxidants on the Growth of Colon Carcinoma Cells in the Presence of Doxorubicin or Vinblastine in Hypoxic or in Ambient Oxygen Conditions

G. Rebel, I. Lelong-Rebel, C. Wersinger, 2003 .

Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutants

A. Sidhu, C. Wersinger, 2003, Neuroscience Letters.

alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.

A. Sidhu, P. Vernier, C. Wersinger, 2004, FEBS letters.

17β‐ and 17α‐estradiol are non‐competitive inhibitors of dopamine uptake: implications for Parkinson's disease models and therapeutics

A. Sidhu, J. Dykens, C. Wersinger, 2005 .

Sensitivity of taurine uptake to oxygen-derived reactive substances in MDR and non-MDR cells

G. Rebel, I. Lelong-Rebel, C. Wersinger, 2001, Amino Acids.

Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.

A. Sidhu, C. Moussa, Y. Tomita, 2004, Biochemistry.

Diminished Expression of Constitutive Nitric Oxide Synthases in the Kidney of Spontaneously Hypertensive Rat

A. Sidhu, U. Kumar, Y. Patel, 2003, Clinical and experimental hypertension.

Attenuation of the norepinephrine transporter activity and trafficking via interactions with α‐synuclein

A. Sidhu, C. Wersinger, Alexis M Jeannotte, 2006, The European journal of neuroscience.

Physiology, Pharmacology and Pathophysiology of the D1-like Family of Dopamine Receptors in the Central Nervous System

S. Senogles, C. Wersinger, B. White, 2003 .

Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation

A. Sidhu, Jun Chen, C. Wersinger, 2004, Molecular and Cellular Neuroscience.

Chronic Stimulation of D1 Dopamine Receptors in Human SK-N-MC Neuroblastoma Cells Induces Nitric-oxide Synthase Activation and Cytotoxicity*

A. Sidhu, Jun Chen, C. Wersinger, 2003, Journal of Biological Chemistry.

Detailed study of the different taurine uptake systems of colon LoVo MDR and non-MDR cell lines

G. Rebel, I. Lelong-Rebel, C. Wersinger, 2000, Amino Acids.

Inflammation and Parkinson's disease.

A. Sidhu, C. Wersinger, 2002, Current drug targets. Inflammation and allergy.

Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

Philippe Vernier, A. Sidhu, P. Vernier, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism

J. Goudreau, T. Duka, A. Sidhu, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Role of α‐Synuclein in Both Neuroprotection and Neurodegeneration

A. Sidhu, C. Moussa, P. Vernier, 2004 .

Does α‐synuclein modulate dopaminergic synaptic content and tone at the synapse?

A. Sidhu, P. Vernier, C. Wersinger, 2004 .

Modulation of dopamine transporter function by α‐synuclein is altered by impairment of cell adhesion and by induction of oxidative stress

A. Sidhu, P. Vernier, D. Prou, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

α‐Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease

A. Sidhu, P. Vernier, C. Wersinger, 2004 .

The role of alpha-synuclein in both neuroprotection and neurodegeneration.

A. Sidhu, C. Moussa, P. Vernier, 2004, Annals of the New York Academy of Sciences.

Modulation of the trafficking of the human serotonin transporter by human alpha‐synuclein

A. Sidhu, M. Rusnák, C. Wersinger, 2006, The European journal of neuroscience.

The Degeneration of Dopamine Neurons in Parkinson's Disease: Insights from Embryology and Evolution of the Mesostriatocortical System

A. Sidhu, P. Vernier, S. Callier, 2004, Annals of the New York Academy of Sciences.

Attenuation of dopamine transporter activity by α-synuclein

A. Sidhu, C. Wersinger, 2003, Neuroscience Letters.

Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.

A. Sidhu, P. Vernier, C. Wersinger, 2004, Biochemistry.

Mutations in the lipid-binding domain of α-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity

A. Sidhu, H. Niznik, P. Vernier, 2003, Molecular and Cellular Neuroscience.

Transcriptional regulation of the α-synuclein gene in human brain tissue

T. Gasser, C. Wersinger, S. Brenner, 2015, Neuroscience Letters.

An Inflammatory Pathomechanism for Parkinsons Disease

A. Sidhu, C. Wersinger, 2006 .

Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.

A. Sidhu, C. Wersinger, 2005, Biochemistry.

An inflammatory pathomechanism for Parkinson's disease?

A. Sidhu, C. Wersinger, 2006, Current medicinal chemistry.

Comparative analyses of α-synuclein expression levels in rat brain tissues and transfected cells

A. Sidhu, C. Wersinger, M. Banta, 2004, Neuroscience Letters.

Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells.

A. Sidhu, C. Wersinger, M. Banta, 2004, Neuroscience letters.

Attenuation of dopamine transporter activity by alpha-synuclein.

A. Sidhu, C. Wersinger, 2003, Neuroscience letters.